Basis: Trailing twelve months (TTM net income over the latest quarterly balance sheet). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on assets (ROA) high or low?
The return on assets (ROA) of 3.54% is 29% below its 5-year average of 5.01%, near the low end of its 5-year range (3.54%–7.36%).
3.93% below its 12-month average of 3.68%.
Reported quarterly return on assets; no daily interpolation. Q2 FY2026 (2026-06-27): 0.83%.
RETURN ON ASSETS (ROA)
3.54%
RETURN ON ASSETS (ROA) AVG TTM
3.68%
RETURN ON ASSETS (ROA) AVG 3Y
4.39%
RETURN ON ASSETS (ROA) AVG 5Y
5.01%
RETURN ON ASSETS (ROA) AVG 10Y
5.77%
RETURN ON ASSETS (ROA) AVG 15Y
6.33%
RETURN ON ASSETS (ROA) AVG 20Y
6.43%
CURRENT VS TTM AVG
-3.93%
CURRENT VS 3Y AVG
-19.32%
CURRENT VS 5Y AVG
-29.39%
CURRENT VS 10Y AVG
-38.69%
CURRENT VS 15Y AVG
-44.03%
CURRENT VS 20Y AVG
-44.92%
SECTOR MEDIAN · HEALTHCARE
5.14%
median of 90 covered companies
CURRENT VS SECTOR MEDIAN
-31.13%
vs the sector median at left
Henry Schein, Inc.
Market Cap
$9.71B
Return on Assets (ROA)
3.54%
TTM Avg
3.68%
3Y Avg
4.39%
5Y Avg
5.01%
Market Cap
$9.74B
Return on Assets (ROA)
11.86%
TTM Avg
10.65%
3Y Avg
7.37%
5Y Avg
5.11%
Market Cap
$10.02B
Return on Assets (ROA)
9.76%
TTM Avg
6.05%
3Y Avg
5.92%
5Y Avg
6.23%
Market Cap
$10.16B
Return on Assets (ROA)
2.17%
TTM Avg
-6.26%
3Y Avg
-11.14%
5Y Avg
1.46%
Market Cap
$10.17B
Return on Assets (ROA)
6.59%
TTM Avg
6.34%
3Y Avg
6.05%
5Y Avg
6.29%
Market Cap
$10.33B
Return on Assets (ROA)
-0.04%
TTM Avg
5.29%
3Y Avg
6.08%
5Y Avg
6.13%
Market Cap
$10.52B
Return on Assets (ROA)
6.44%
TTM Avg
6.68%
3Y Avg
6.69%
5Y Avg
12.75%
Market Cap
$10.56B
Return on Assets (ROA)
4.50%
TTM Avg
3.10%
3Y Avg
3.02%
5Y Avg
7.71%
Market Cap
$10.58B
Return on Assets (ROA)
9.58%
TTM Avg
8.61%
3Y Avg
6.84%
5Y Avg
6.99%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Henry Schein, Inc. (HSIC) | $9.71B | 3.54% | 3.68% | 4.39% | 5.01% |
| Insulet Corp. (PODD)vs › | $9.74B | 11.86% | 10.65% | 7.37% | 5.11% |
| Globus Medical, Inc. (GMED)vs › | $10.02B | 9.76% | 6.05% | 5.92% | 6.23% |
| Bio-Rad Laboratories, Inc. (BIO)vs › | $10.16B | 2.17% | -6.26% | -11.14% | 1.46% |
| The Ensign Group, Inc. (ENSG)vs › | $10.17B | 6.59% | 6.34% | 6.05% | 6.29% |
| Molina Healthcare, Inc. (MOH)vs › | $10.33B | -0.04% | 5.29% | 6.08% | 6.13% |
| Align Technology, Inc. (ALGN)vs › | $10.52B | 6.44% | 6.68% | 6.69% | 12.75% |
| The Cooper Companies, Inc. (COO)vs › | $10.56B | 4.50% | 3.10% | 3.02% | 7.71% |
| Universal Health Services, Inc. (UHS)vs › | $10.58B | 9.58% | 8.61% | 6.84% | 6.99% |
| Oscar Health, Inc. (OSCR)vs › | $8.11B | 4.91% | -3.24% | -6.85% | -10.42% |
ROA
3.5%
ROE
12.8%
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2025-12-27 | 3.55% |
| 2024-12-28 | 3.82% |
| 2023-12-31 | 3.93% |
| 2022-12-31 | 6.25% |
| 2021-12-31 | 7.36% |
| 2020-12-31 | 5.17% |
| 2019-12-31 | 7.10% |
| 2018-12-31 | 6.30% |
| 2017-12-31 | 5.17% |
| 2016-12-31 | 7.50% |
| 2015-12-31 | 7.36% |
| 2014-12-31 | 7.59% |
| 2013-12-31 | 7.90% |
| 2012-12-31 | 7.28% |
| 2011-12-31 | 7.76% |
| 2010-12-31 | 7.16% |
| 2009-12-31 | 8.05% |
| 2008-12-31 | 6.87% |
| 2007-12-31 | 7.09% |
| 2006-12-31 | 6.34% |
| 2005-12-31 | 5.41% |
| 2004-12-31 | 5.27% |
| 2003-12-31 | 7.56% |
| 2002-12-31 | 7.57% |
| 2001-12-31 | 6.31% |
| 2000-12-31 | 4.61% |
| 1999-12-31 | 4.18% |
| 1998-12-31 | 1.69% |
| 1997-12-31 | -0.12% |
| 1996-12-31 | 3.07% |
